Gerald P. Parzmair
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
First-In-Human, Randomized, Placebo-Controlled, SAD and MAD Trial to Evaluate Safety, Tolerability, and PK/PD Modeling of Potravitug in Healthy Adults.
Journal: Clinical and translational science
Published: April 03, 2025
Safety and Immunogenicity of Recombinant Bacille Calmette-Guérin Strain VPM1002 and Its Derivatives in a Goat Model.
Journal: International journal of molecular sciences
Published: January 25, 2023
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 25, 2022
Enhanced Susceptibility of ADAP-Deficient Mice to Listeria monocytogenes Infection Is Associated With an Altered Phagocyte Phenotype and Function.
Journal: Frontiers in immunology
Published: June 14, 2021
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy.
Journal: Oncoimmunology
Published: July 09, 2019
ADAP plays a pivotal role in CD4+ T cell activation but is only marginally involved in CD8+ T cell activation, differentiation, and immunity to pathogens.
Journal: Journal of leukocyte biology
Published: February 24, 2016
Phosphoinositide-dependent protein kinase 1 (PDK1) mediates potent inhibitory effects on eosinophils.
Journal: European journal of immunology
Published: September 12, 2014
Opposing roles of prostaglandin D2 receptors in ulcerative colitis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 15, 2014
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Journal: The Journal of biological chemistry
Published: November 20, 2012
Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.
Journal: The Journal of allergy and clinical immunology
Published: December 29, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026